1,693
Views
13
CrossRef citations to date
0
Altmetric
Articles

Aspartic acid derivatized hydroxylated fullerenes as drug delivery vehicles for docetaxel: an explorative study

, , , & ORCID Icon
Pages 1763-1772 | Received 26 Jul 2017, Accepted 11 Oct 2017, Published online: 25 Oct 2017

References

  • Zhang H, Li R, Lu X, et al. Docetaxel-loaded liposomes: preparation, pH sensitivity, pharmacokinetics, and tissue distribution. J Zhejiang Univ Sci B. 2012;13:981–989.
  • Prakash O, Kumar A, Kumar P, et al. Anticancer potential of plants and natural products: a review. Am J Pharmacol Sci. 2013;1:104–115.
  • Guenard D, Gueritte-Voegelein F, Potier P. Taxol and taxotere: discovery, chemistry, and structure-activity relationships. Acc Chem Res. 1993;26:160–167.
  • Raza K, Thotakura N, Kumar P, et al. C60-fullerenes for delivery of docetaxel to breast cancer cells: a promising approach for enhanced efficacy and better pharmacokinetic profile. Int J Pharm. 2015;495:551–559.
  • Kumar P, Raza K, Kaushik L, et al. Role of colloidal drug delivery carriers in taxane-mediated chemotherapy: a review. Curr Pharm Des. 2016;22:5127–5143.
  • Wang H, Xu Y, Zhou X. Docetaxel-loaded chitosan microspheres as a lung targeted drug delivery system: in vitro and in vivo evaluation. Int J Mol Sci. 2014;15:3519–3532.
  • Shi J, Zhang H, Wang L, et al. PEI-derivatized fullerene drug delivery using folate as a homing device targeting to tumor. Biomaterials. 2013;34:251–261.
  • Arora S, Saharan R, Kaur H, et al. Attachment of docetaxel to multiwalled carbon nanotubes for drug delivery applications. Adv Sci Lett. 2012;17:70–75.
  • Musumeci T, Ventura CA, Giannone I, et al. PLA/PLGA nanoparticles for sustained release of docetaxel. Int J Pharm. 2006;325:172–179.
  • Prylutska SV, Skivka LM, Didenko GV, et al. Complex of C60 fullerene with doxorubicin as a promising agent in antitumor therapy. Nanoscale Res Lett. 2015;10:499.
  • Raza K, Kumar M. C60-fullerenes as drug delivery carriers for anticancer agents: promises and hurdles. Pharm Nanotechnol. 2017;5:1–1.
  • Olah GA, Bucsi I, Aniszfeld R, et al. Chemical reactivity and functionalization of C60 and C70 fullerenes. Carbon NY. 1992;30:1203–1211.
  • Maggini M, Scorrano G, Bianco A, et al. Addition reactions of C60 leading to fulleroprolines. J Chem Soc Chem Commun. 1994;45:305.
  • Hirsch A, Brettreich M. Fullerenes: chemistry and reactions. Weinheim (Germany): Wiley-VCH; 2005.
  • Avent AG, Boltalina OV, Lukonin AY, et al. Isolation and characterisation of C60F16; a key to understanding fullerene addition patterns. J Chem Soc Perkin Trans. 2000;2:1359–1361.
  • Savage N, Diallo MS. Nanomaterials and water purification: opportunities and challenges. J Nanopart Res. 2005;7:331–342.
  • Martín N, Elliott B, Hudson JS, et al. New challenges in fullerene chemistry. Chem Commun. 2006;12:2093–2104.
  • Injac R, Prijatelj M, Strukelj B. Fullerenol nanoparticles: toxicity and antioxidant activity methods. Mol Biol. 2013;1028:75–100.
  • Aoshima H, Saitoh Y, Ito S, et al. Safety evaluation of highly purified fullerenes (HPFs): based on screening of eye and skin damage. J Toxicol Sci. 2009;34:555–562.
  • Johnson-Lyles DN, Peifley K, Lockett S, et al. Fullerenol cytotoxicity in kidney cells is associated with cytoskeleton disruption, autophagic vacuole accumulation, and mitochondrial dysfunction. Toxicol Appl Pharmacol. 2010;248:249–258.
  • Misra C, Thotakura N, Kumar R, et al. Improved cellular uptake, enhanced efficacy and promising pharmacokinetic profile of docetaxel employing glycine-tethered C 60-fullerenes. Mater Sci Eng C. 2017;76:501–508.
  • Raza K, Kumar N, Misra C, et al. Dextran-PLGA-loaded docetaxel micelles with enhanced cytotoxicity and better pharmacokinetic profile. Int J Biol Macromol. 2016;88:206–212.
  • Zhang JM, Yang W, He P, et al. Efficient and convenient preparation of water-soluble fullerenol. Chin J Chem. 2010;22:1008–1011.
  • Narang CK, Iyer V, Mathur NK. Microdetermination of hydroxyl groups via esterification with succinic and o-sulfobenzoic anhydrine. Microchem J. 1965;9:408–410.
  • Thakur CK, Thotakura N, Kumar R, et al. Chitosan-modified PLGA polymeric nanocarriers with better delivery potential for tamoxifen. Int J Biol Macromol. 2016;93:381–389.
  • Raza K, Kumar D, Kiran C, et al. Conjugation of docetaxel with multiwalled carbon nanotubes and co-delivery with piperine: implications on pharmacokinetic profile and anti-cancer activity. Mol Pharmaceutics. 2016;13:2423–2432.
  • Kumar P, Kumar R, Singh B, et al. Biocompatible phospholipid-based mixed micelles for tamoxifen delivery: promising evidences from –in-vitro anticancer activity and dermatokinetic studies. AAPS Pharm Sci Tech. 2017;18:2037–2044.
  • Madhwi Kumar R, Kumar P, et al. In vivo pharmacokinetic studies and intracellular delivery of methotrexate by means of glycine-tethered PLGA-based polymeric micelles. Int J Pharm. 2017;519:138–144.
  • Joshi M, Kumar P, Kumar R, et al. Aminated carbon-based “cargo vehicles” for improved delivery of methotrexate to breast cancer cells. Mater Sci Eng C. 2017;75:1376–1388.
  • Kumar P, Sharma G, Kumar R, et al. Vitamin-derived nanolipoidal carriers for brain delivery of dimethyl fumarate: a novel approach with preclinical evidence. ACS Chem Neurosci. 2017;8:1390–1396.
  • Zhang J, Chen XG, Huang L, et al. Self-assembled polymeric nanoparticles based on oleic acid-grafted chitosan oligosaccharide: biocompatibility, protein adsorption and cellular uptake. J Mater Sci Mater Med. 2012;23:1775–1783.
  • Kumar P, Sharma G, Kumar R, et al. Enhanced brain delivery of dimethyl fumarate employing tocopherol-acetate-based nanolipidic carriers: evidence from pharmacokinetic, biodistribution, and cellular uptake studies. ACS Chem Neurosci. 2017;8:860–865.
  • Daniel WW, Cross CL. Biostatistics: a foundation for analysis in the health sciences (Wiley Series in Probability and Statistics). Hoboken, NJ: John Wiley & Sons Inc; 2013.
  • Dash S, Murthy PN, Nath L, et al. Kinetic modeling on drug release from controlled drug delivery systems. Acta Pol Pharm. 67:217–223.
  • Tang X, Cai S, Zhang R, et al. Paclitaxel-loaded nanoparticles of star-shaped cholic acid-core PLA-TPGS copolymer for breast cancer treatment. Nanoscale Res Lett. 2013;8:420.
  • Pavia DL, Lampman GM, Kriz GS, et al. Introduction to spectroscopy. Stamford (CT): Brooks/Cole, Cengage Learning; 2009.
  • Sathish M, Miyazawa K, Mukhopadhyay P, et al. Selective precipitation of tubular-like short fullerene (C60) whiskers at liquid–liquid interface. Cryst Eng Comm. 2010;12:4146.
  • Sathish MK, Miyazawa A, Sasaki T. Nanoporous fulleren nano-whiskers. Chem Mater. 2007;19:2398–2400.
  • Clausell JV, Bastida J, Serrano FJ, et al. A new FESEM procedure for assessment of XRD microstructural data of kaolinites. Appl Clay Sci. 2007;37:127–132.
  • Nimesh S, Chan R, Gupta N. Advances in nanomedicine for the delivery of therapeutic nucleic acids. India: Elsevier Science & Technology; 2017.
  • Scheife RT. Protein binding: what does it mean? DICP. 1989;23:S27–S31.
  • Fröhlich E. Hemocompatibility of inhaled environmental nanoparticles: potential use of in vitro testing. J Hazard Mater. 2017;336:158–167.
  • Xu X, Li R, Ma M, et al. Multidrug resistance protein P-glycoprotein does not recognize nanoparticle C60: experiment and modeling. Soft Matter. 2012;8:2915.
  • Bareford LM, Swaan PW. Endocytic mechanisms for targeted drug delivery. Adv Drug Deliv Rev. 2007;59:748–758.
  • Nielsen GD, Roursgaard M, Jensen KA, et al. In vivo biology and toxicology of fullerenes and their derivatives. Basic Clin Pharmacol Toxicol. 2008;103:197–208.
  • Shargel L, Wu-Pong S, Yu A. Applied biopharmaceutics and pharmacokinetics. 5th ed. USA: McGraw Hill Professional; 2004.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.